HDE H090002 supplement record S001 and S002 (post-approval study protocol approvals) (2013)

Government Record · U.S. Food and Drug Administration, CDRH · November 13, 2013

U.S. Food et al., 2013-11-13: The complete HDE record set for H090002: the original approval and two supplements, both decided 13 November 2013, both administrative approvals of the post-approval study protocol.

Approval of the post-approval study protocol.

n/a

U.S. Food et al., 2013-11-13: The complete HDE record set for H090002: the original approval and two supplements, both decided 13 November 2013, both administrative approvals of the post-approval study protocol. Searched as of 18 November 2026 (database 'Page Last Updated 11/16/2026'). Only three records exist. No supplement expands the indication beyond cervical carcinoma, and none covers soft tissue sarcoma – relevant because the EORTC trials in C1 report sarcoma benefits that are not reflected in any U.S. marketing authorization. No pdf_url: the supplement pages are HTML records without a linked PDF. Study type: regulatory record.